Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on TechCrunch.